Sunosi

Active Ingredient(s): Solriamfetol
FDA Approved: * March 20, 2019
Pharm Company: * JAZZ PHARMA IRELAND LTD
Category: Narcolepsy

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".

Sunosi Overview

Solriamfetol, sold under the brand name Sunosi, is a medication used for the treatment of excessive sleepiness associated with narcolepsy and sleep apnea.[1] It is derived from d-phenylalanine and its chemical name is (R)-2-amino-3-phenylpropylcarbamate hydrochloride.[3] It is a norepinephrine–dopamine reuptake inhibitor (NDRI). Common side effects include headache, nausea, anxiety, and trouble sleeping.[1] The drug was discovered by a sub...

Read more Sunosi Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Solriamfetol

Recent Sunosi Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

NDC Database Records for Sunosi: (2 results)

Sorted by National Drug Code

• 68727-350 Sunosi 75 mg Oral Tablet, Film Coated by Jazz Pharmaceuticals, Inc.
• 68727-351 Sunosi 150 mg Oral Tablet, Film Coated by Jazz Pharmaceuticals, Inc.

Other drugs which contain Solriamfetol or a similar ingredient: (1 result)

• SOLRIAMFETOL